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Connexin 43 (Cx43), the principal gap junction protein in vascular smooth muscle cells
(VSMCs), regulates movement of ions and other signaling molecules through gap junction
intercellular communication (GJIC) and plays important roles in maintaining normal vessel
function; however, many of the signaling mechanisms controlling Cx43 in VSMCs are not
clearly described. The goal of this study was to investigate mechanisms of Cx43 regula-
tion with respect to VSMC proliferation. Treatment of rat primary VSMCs with the cAMP
analog 8Br-cAMP , the soluble guanylate cyclase (sGC) stimulator BAY 41-2272 (BAY), or the
Cx inducer diallyl disulﬁde (DADS) signiﬁcantly reduced proliferation after 72h compared
with vehicle controls. Bromodeoxyuridine uptake revealed reduction (p <0.05) in DNA
synthesis after 6h and ﬂow cytometry showed reduced (40%) S-phase cell numbers after
16h in DADS-treated cells compared with vehicle controls. Cx43 expression signiﬁcantly
increased after 270min treatment with 8Br-cAMP , 8Br-cGMP , BAY or DADS. Inhibition of
PKA, PKG or PKC reversed 8Br-cAMP-stimulated increases in Cx43 expression, whereas
only PKG or PKC inhibition reversed 8Br-cGMP- and BAY-stimulated increases in total Cx43.
Interestingly, stimulation of Cx43 expression by DADS was not dependent on PKA, PKG or
PKC. Using ﬂuorescence recovery after photobleaching, only 8Br-cAMP or DADS increased
GJIC with 8Br-cAMP mediated by PKC and DADS mediated by PKG. Further, DADS signif-
icantly increased phosphorylation at MAPK-sensitive Serine (Ser)255 and Ser279, the cell
cycle regulatory kinase-sensitive Ser262 and PKC-sensitive Ser368 after 30min while 8Br-
cAMP signiﬁcantly increased phosphorylation only at Ser279 compared with controls.This
study demonstrates that 8Br-cAMP- and DADS-enhanced GJIC rather than Cx43 expres-
sion and/or phosphorylation plays important roles in the regulation of VSMC proliferation
and provides new insights into the growth-regulatory capacities of Cx43 in VSM.
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INTRODUCTION
Coordination of vascular cell responses is necessary for normal
vessel function and is largely regulated by ionic intercellular cou-
pling via gap junctions. Gap junctional intercellular communica-
tion (GJIC) uniquely allows the cellular exchange of metabolites,
ions,and other small molecules such as second messengers which
playimportantrolesintransverseandlongitudinalsignalinginthe
vascularbed(Coutinhoetal.,2003;Liaoetal.,2007;Chadjichristos
et al., 2008). Intercellular communication through gap junctions
in cardiovascular tissues is involved in diverse processes such as
determinationofvasomotortone,celldifferentiation,growthcon-
trol, embryonic development, and coordination of contraction
of cardiac muscle cells (Yamasaki et al., 1996; Liao et al., 2007;
Chadjichristos et al., 2008). Bidirectional cellular communica-
tion conducted by gap junctions is also believed to be integral
in acetylcholine-induced vasoconstriction (Figueroa and Duling,
2009) and in maintaining cell quiescence (Zhang et al.,2003).
Gap junctions are comprised of connexin (Cx) proteins
(Kumar and Gilula, 1996; Yamasaki and Naus, 1996) and serve
as transmembrane channels that act as intercellular conduits for
GJIC. In the vasculature, gap junction channels are formed from
combinationsofoneormoreofthefourconnexinproteinisomers:
Cx37,40,43,and/or45(Littleetal.,1995;EvansandMartin,2002;
Johnstone et al.,2009) and the predominant connexin in vascular
smooth muscle (VSM) is Cx43 (Haeﬂiger et al., 2004; Saitongdee
etal.,2004;Isaksonetal.,2006).ReductioninCx43proteinexpres-
sion and functionality have been associated with enhanced VSM
cell (VSMC) proliferation and differentiation in atherosclerotic
plaques (Kwak et al., 2002); however, the mechanisms for altered
Cx43expressioninatherogenesishavenotbeenwelldescribedbut
are thought to contribute to its disease progression. Studies have
demonstratedthatlossofCx43(Solanetal.,2003;Shaoetal.,2005;
Norris et al., 2008) or altered Cx phosphorylation status (Dang
et al., 2006; Solan and Lampe, 2007) is sufﬁcient to enhance the
proliferative capacity of cells. Cx43 may undergo multiple phos-
phorylation events and at least ﬁve phosphorylated Serines (Ser)
have been detected on Cx43 isolated from non-stimulated cells
and several more have been identiﬁed under growth
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factor- or kinase-stimulated conditions (Lampe and Lau, 2004).
These phosphorylation events correlate with changes in assembly
and degradation of Cx43 gap junction channels and thus could
play important roles in regulating GJIC (Cooper et al., 2000), yet
theirphysiologicalsigniﬁcanceparticularlyinVSMremainslargely
uncharacterized.
Cyclic AMP (cAMP) and cyclic GMP (cGMP) are ubiquitous
second messengers that are involved in a variety of functions dur-
ingvascularhomeostasisandfollowinginjuryordisease;however,
the exact roles for cAMP and cGMP in the regulation of connex-
ins and GJIC are not clear. It has been reported that activation of
the nitric oxide (NO)/cGMP system induces Cx43 expression and
increasesGJIC (Yaoetal.,2005),yetfullcharacterization of cAMP
and cGMP and their physiological inﬂuence on Cx43 expression
and functionality inVSM is warranted.
The overall objective of the present study was to determine the
relation between Cx43 expression, functionality, and phosphory-
lation states with respect to cell proliferation in VSMCs in the
presence of cAMP and cGMP analogs and in comparison to the
indirect soluble guanylate cyclase (sGC) stimulator BAY 41-2272
(BAY) and the Cx43 stimulant and garlic compound diallyl disul-
ﬁde (DADS). In summary, results from this study show that an
increase in Cx43-mediated GJIC is essential for control of prolif-
eration in primary VSMCs and that enhanced expression and/or
differential phosphorylation of Cx43 alone do not serve as effec-
tivegrowthregulators.Moreover,evidenceispresentedsupporting
roles for 8Br-cAMPand DADS and physiologically effective agents
in the control of VSM growth.
MATERIALS AND METHODS
ISOLATION AND CULTURE OF RAT PRIMARY VSMCs
This study abided by the guidelines of the East Carolina Uni-
versity Animal Care and Use Committee and conformed to
the Guide for the Care and Use of Laboratory Animals (US
NIH, Pub. No. 85–23, rev. 1996). Male Sprague-Dawley rats
(100–125g) were anesthetized [ketamine (90mg/ml), xylazine
(10mg/ml; 1ml/kg, i.p.)] and euthanized by pneumothorax
and exsanguination. Vascular SMCs (VSMCs) were harvested
from the thoracic aorta and isolated by collagenase and elas-
tase digestion as described (Durante et al., 1993; Liu et al.,
2009). Cells were cultured serially (passage 1–6) in Dulbecco’s
minimum essential media (DMEM) supplemented with 10%
fetal bovine serum (FBS), 2mM l-glutamine, sodium pyruvate,
5mM HEPES, and Primocin (100mg/l) in the presence of 95%
air/5% CO2.
TREATMENTS
Unless otherwise stated, VSMCs were treated with 8Br-cAMP
or 8Br-cGMP (Adderley et al., 2012) at 100mM, BAY 41-2272
at 100nM, or DADS at 50mM. For treatments involving kinase
inhibition, VSMC were treated with PKI (10mM; Schlegel and
Waschke,2009)forinhibitionof PKA,DT2(YGRKKRRQRRRPP-
LRKKKKKH-amide; 10mM; Dostmann et al., 2002; Dey
et al., 2005) to inhibit PKG, or calphostin-C (CalC; 100nM;
Touyz and Schiffrin, 1997) to inhibit PKC for 15min prior
to treatment with vehicle, 8Br-cAMP, 8Br-cGMP, BAY, or
DADS.
MTT ASSAY
Vascular smooth muscle cells were plated onto 96-well plates at
21,000 cells/well and treated with 8Br-cAMP, 8Br-cGMP, BAY, or
DADS. After 12 or 72h 2,5-diphenyltetrazolium bromide (MTT)
solutionwasaddedtothemediaandthecellsincubatedfor3h.The
MTT-containing media was discarded and the cells were gently
washed with PBS. Formazan formed within the cells was then dis-
solvedinacetic-isopropanolandtheplatewasreadat570nmwith
correction at 750nm. The optical density (OD) of the treatments
was normalized to vehicle controls.
HEMOCYTOMETRY AND NEUTRAL RED UPTAKE
Hemocytometry was performed after 72h to obtain viable cell
numbers and Neutral Red Uptake was performed after 12h as an
estimate of cellular toxicity per established protocols (Mendelev
et al., 2009; Joshi et al., 2011).
BrdU UPTAKE
The rate of DNA synthesis was measured with 5-bromo-20-
deoxyuridine (BrdU) labeling (Giordano et al., 2008) with detec-
tion(DetectionKitII,RocheDiagnosticsCorporation,Indianapo-
lis, IN, USA) following manufacturer’s instructions. Brieﬂy, cells
wereplatedonto96-wellplatesat21,000cells/well.Afterquiescing
overnight, cells were treated with 8Br-cAMP, 8Br-cGMP, BAY, or
DADS for 2h followed by BrdU treatment for 4h. Cells were ﬁxed
and incubated in the presence of the anti-BrdU antibody for 1h,
after which the antibody was removed and the detection reagent
added. The plate was read on a spectrophotometer at 370nm with
a reference at 492nm. The OD of the treatments was normalized
to vehicle controls.
CELL CYCLE ANALYSIS
Flow cytometric cell cycle analysis was performed as described
(Joshi et al., 2011). Brieﬂy, VSMCs were seeded in 24-well plates
(100,000 cells/well) and after adherence were quiesced overnight
in DMEM containing 0.2% FBS. Cells were treated with vehicle,
8Br-cAMP or DADS for 16h. The cells were trypsinized, ﬁxed in
coldethanol,stainedwithpropidiumiodide,andsubjectedtoﬂow
cytometry (Accuri C6).
IN-CELL WESTERN BLOTTING
Theeffectsof 8Br-cAMP,8Br-cGMP,BAY,orDADSaloneorinthe
presence of PKA, PKG, or PKC inhibitors PKI, DT2, or CalC on
Cx43 expression inVSMCs were studied using the in-cellWestern
(ICW) method (Chen et al., 2005). Primary VSMCs were seeded
in black 96-well ﬂat bottom plates at 21,000 cells/well and fol-
lowing attachment were treated with respective agents for 30 or
270min or 24h. For inhibitor studies,VSMCs were pretreated for
15min with PKI (10mM), DT2 (10mM), or CalC (100nM) fol-
lowed by treatment with 8Br-cAMP, 8Br-cGMP, BAY, or DADS
for 270min. Reactions were stopped by replacing media with
4% phosphate-buffered formalin. Fixed cells were permeabilized
with 0.1% Triton, blocked, and incubated with IR-tagged rabbit
antibodies against Cx43 or the phosphorylated forms of Cx43 at
Serines 255, 262, 279, and 368 (Cell Signaling) along with mouse
a-tubulin (Sigma) as the housekeeping control at 1:500 dilutions
overnight at 4˚C. Cells were washed with PBS-Tween and incu-
bated with anti-rabbit IR 800 and anti-mouse IR 680 (Rockland)
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secondary antibodies for 1h. The proteins were quantiﬁed by
ﬂuorescence (LiCor Odyssey) and normalized with respect to a-
tubulinwithineachwell.Alltreatmentswerenormalizedtovehicle
control.
WESTERN BLOTTING
Western blotting was performed on whole cell lysates as previ-
ously described (Mendelev et al., 2009) with slight modiﬁcations.
After treatment with 8Br-cAMP, 8Br-cGMP, BAY, or DADS for
270min,cells were collected,homogenized,sonicated,boiled,and
SDS-PAGEwasperformedusing20mgproteinsamples.Thesepa-
rated blots were transferred to nitrocellulose membrane, blocked,
and incubated overnight at 4˚C with IR-tagged antibodies against
rabbit Cx43 protein (Millipore) and mouse a-tubulin (Sigma)
at 1:3000 dilutions. After washes the membranes were incubated
in anti-rabbit IR800 and anti-mouse IR680 secondary antibodies
(Rockland;1:3000)for1hatroomtemperature.Blotswerewashed
andproteinswerequantiﬁedbyﬂuorescencedensitometry(Li-Cor
Odyssey) and normalized with respect to a-tubulin.
GAP JUNCTION COMMUNICATION
Gap junction-mediated cell–cell communication was measured
using a ﬂuorescence recovery after photobleaching (FRAP) assay
as described (Goodwin and Kenworthy, 2005; Shen et al., 2010)
with slight modiﬁcations. In this assay,recovery of ﬂuorescence in
a previously bleached cell is the result of inﬂux of native dye from
neighboring cells via gap junctions (Wade et al., 1986; Muller-
Borer et al., 2004; Shen et al., 2010). Thus, the FRAP assay is a
directmeasureof gapjunctionpermeabilityandconductanceand
is a reliable measure of GJIC functionality. Moreover, FRAP is
non-invasive, highly sensitive, and faster compared to more tra-
ditional GJIC approaches such as microinjection and dye transfer
(Shen et al., 2010). Lastly, in this study FRAP measurements were
performed after 15-min treatment,a physiologically relevant time
point for the measurement of acute changes in gap junction func-
tion. Brieﬂy,FRAP was performed using a laser scanning confocal
microscope (Leica TCS-SP, Heidelberg, Germany), mounted on a
Leica inverted microscope with a 63 water objective. Primary
VSMCs were seeded (s35,000 cells) and grown to conﬂuence on
glass coverslips. For the loading of Calcein AM (Invitrogen), cells
werewashedwithwarmPBSandincubatedinphenol-freeDMEM
containingCalceinAM(1mM)for45min,washedwithwarmPBS
andincubatedin10%FBSinDMEM.Cellsweretreatedfor15min
with either 8Br-cAMP,8Br-cGMP,BAY,or DADS and subjected to
FRAP. In the inhibitor study with 8Br-cAMP and DADS, 15min
treatment of the respective PKA, PKG, and PKC inhibitors PKI
(10mM), DT2 (10mM), or CalC (100nM) was followed by treat-
ment with 8Br-cAMP or DADS. Individual cells connected with
at least four cells on all the sides were selected for photobleaching.
Calcein AM (Invitrogen Corp, Carlsbad, CA, USA) was excited
by a high intensity argon laser pulse at 488nm to bleach intra-
cellular Calcein in selected cells and captured through grating at
530/30nm. The bleached cell was then monitored, and images
were acquired continuously every 10s for the initial minute, fol-
lowed by 30 second intervals for 2 minutes and 1 minute intervals
for another 2 minutes. GJIC between a cell and its neighbors
was quantiﬁed by measuring the initial rate and percentage of
ﬂuorescencerecovery.Non-photobleachedcellsweremonitoredas
controlsforspontaneousphotobleaching.Therateof ﬂuorescence
recovery was estimated using the Zen (2009) software (Carl Zeiss)
and the initialrecovery rate constants werecompared between the
treated and vehicle controls. All treatments were normalized to
vehicle control and expressed as percentage of vehicle controls.
STATISTICAL ANALYSES
Data were analyzed using Microsoft Excel 2007 and Sigma Plot
11 (SPSS, Inc.). Comparisons between treatment groups were
made using one-way analysis of variance (ANOVA) and a mul-
tiple comparison Newman–Keuls post hoc test or Student’s t-test
as indicated. All data are presented as meanSEM. A p-value of
<0.05 is considered statistically signiﬁcant for all comparisons.
RESULTS
VSMC GROWTH
Growth of VSMCs was assessed through use of the MTT assay
and hemocytometric cell counts after 72h, ﬂow cytometry after
16h,andBrdUincorporationafter6h.Mitochondrialdysfunction
and cellular toxicity from all treatments were also evaluated after
12h. Using the MTT assay after 72h, 8Br-cAMP (100mM), BAY
(100nM), or DADS (50mM) signiﬁcantly reduced VSMC prolif-
eration compared with vehicle controls; however, 8Br-cGMP was
without effect (Figure 1A). In agreement, hemocytometry after
72h also revealed signiﬁcant reduction in cell numbers following
treatmentwith8Br-cAMP(100mM)orBAY(100nM),andanon-
signiﬁcanttrend(s20%reduction;p D0.06)wasobservedforthe
DADS treatment group (Figure 1B). The MTT assay performed
after 12h indicated no observable mitochondrial dysfunction in
any cohort (Figure 1C). Similarly, Neutral Red Uptake after 12h
showed no signiﬁcant differences between treatment and vehicle
control groups (data not shown).
Following BrdU uptake for 6h, DADS (50mM) signiﬁcantly
reduced (20%) the rate of DNA synthesis compared with vehicle
controls (Figure 2), yet 8Br-cAMP, 8Br-cGMP, or BAY showed no
effects on DNA synthesis at this time point.
Flow cytometry performed as a measure of cell cycle progres-
sion showed that DADS signiﬁcantly reduced the number of cells
in the S-phase (s40%) compared with vehicle controls after 16h,
while8Br-cAMPcausednon-signiﬁcantdecreasesincellnumbers
intheSandG2/Mphasesandanon-signiﬁcantincreaseinG0/G1
cells (Figure 3).
Cx43 EXPRESSION
Using both IR-basedWestern and ICW analyses,incubation of rat
primary VSMCs with 8Br-cAMP or 8Br-cGMP (100mM), BAY
(100nM), or DADS (50mM) signiﬁcantly increased total Cx43
expression (normalized to a-tubulin) compared with vehicle con-
trols after 270min (Figure 4). Figure 4A shows densitometry
results following ICW, and all agents increased total Cx43 by 20–
25%. Interestingly, after 24h only DADS signiﬁcantly increased
total Cx43 expression (Figure 4B). Of note, reducing the incu-
bation period to 30min in the presence of the four compounds
showed no changes in Cx43 expression (data not shown). Using
traditional, IR-Western blotting, the same trends were observed
for increased total Cx43 expression (data not shown), yet the
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FIGURE 1 | Effects of cyclic nucleotide or Cx43 stimulation on
VSMC proliferation. (A) In rat primary VSMCs in the presence of 10%
serum for 72h and using the MTT assay, 8Br-cAMP (100mM), the sGC
stimulator BAY (100nM) or the garlic-derived Cx inducer DADS (50mM)
signiﬁcantly reduced rat primary VSMC numbers compared with
vehicle controls. Data are meanSEM with an nD6. (B) Using
hemocytometry after 72h, both 8Br-cAMP and BAY signiﬁcantly
reduced cell numbers by s40%, and the presence of DADS reduced
cell numbers by s20% (p D0.06). Data are meanSEM of two
independent experiments each with nD3–4. (C) MTT assay performed
on VSMCs after 12h shows no observable changes in any treatment
group. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p <0.05 compared with
normalized vehicle controls.
FIGURE 2 | Effects of cyclic nucleotide or Cx43 stimulation onVSMC
DNA synthesis. In rat primary VSMCs in the presence of 10% serum for
6h, DADS (50mM) signiﬁcantly reduced the rate of DNA synthesis by 20%
compared with vehicle controls estimated by BrdU incorporation. Data are
meanSE from three independent experiments each with an nD6.
Student–Newman–Keuls method for multiple comparisons following
one-way ANOVA was used. *p <0.05compared with normalized vehicle
controls.
extent of increases was much higher than that observed with
ICW.ArepresentativeIR-WesternblotfortotalCx43expressionis
shown in Figure 4C. Figure 4D shows a representative photomi-
crograph of conﬂuent VSMCs following immunocytochemical
staining for Cx43which shows punctate presenceof gap junctions
predominantly at cell-to-cell contacts (indicated by arrows).
EFFECTS OF KINASE INHIBITION ON STIMULATED Cx43 EXPRESSION
KinaseregulationofCx43expressioninthepresenceof8Br-cAMP,
8Br-cGMP, BAY,or DADS was tested using selective kinase block-
ade and evaluated through ICW analysis. Respective inhibition
of PKA, PKG, and PKC by PKI, DT-2, and CalC signiﬁcantly
reversedthestimulatoryeffectsof8Br-cAMPontotalCx43expres-
sion (Figure 5A). In comparison, only the inhibition of PKG and
PKC (by DT-2 and CalC,respectively) reversed the stimulation of
Cx43 expression induced by both the direct-activating 8Br-cGMP
(Figure 5B) and the indirect sGC stimulator BAY (Figure 5C).
Inhibition of any of the kinases, PKA, PKG, or PKC, did not
have any effect on DADS-induced stimulation of Cx43 expres-
sion (Figure 5D). Lastly, each inhibitor alone failed to alter basal
(vehicle-treated) total Cx43 expression (Figure 5E). A summary
of results from the kinase inhibitor studies on Cx43 expression is
shown in Table 1.
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FIGURE 3 | Effects of 8Br-cAMP and DADS on 10% FBS-stimulated
VSMC cell cycle progression. Using ﬂow cytometry after 16h incubation,
a 40% reduction in the percentage of cells in the S-phase was observed in
the presence of DADS (50mM) with no signiﬁcant changes in the G0/G1 or
G2/M phases compared with vehicle controls. Data are meanSEM with
an nD3. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p <0.05compared with vehicle
controls.
CELL-TO-CELL COMMUNICATION
Using FRAP as a measure of GJIC and gap junction function-
ality, incubating cells for 15min in the presence of 8Br-cAMP
increased GJIC by 50% and in the presence of DADS by 80%
over vehicle controls while the presence of 8Br-cGMP or BAY
had no effect (Figure 6A). After 270min 8Br-cAMP or DADS
failed to enhance GJIC (data not shown). Representative pho-
tomicrographs of adherent VSMCs subjected to FRAP analysis
are shown (Figures 6B–E) with the photobleached cell of interest
outlined.Figure6Bshowsacellimmediatelypriortophotobleach-
ing; Figure 6C shows that cell immediately after photobleaching;
Figure 6D shows the cell 2.5min after photobleaching and some
degree of ﬂuorescent recovery is apparent; Figure 6E shows the
cell4.5minafterphotobleachingattheconclusionof ﬂuorescence
recovery.
To examine kinase involvement in the acute stimulation of
GJIC by 8Br-cAMP or DADS, FRAP was studied following select
kinase inhibition in the presence of 8Br-cAMP or DADS. GJIC
stimulated by 8Br-cAMP was reversed by PKC inhibition alone
(Figure 7A), whereas GJIC stimulated by DADS was markedly
subdued (p D0.06) by DT-2-mediated inhibition of PKG alone
(Figure 7B).
Cx43 PHOSPHORYLATION
Site-speciﬁc phosphorylation of Cx43 was studied at four sites
known to be sensitive to kinase activation: Ser255 and Ser279
(MAPK-speciﬁc), Ser262 (p34cdc2 kinase-speciﬁc), and Ser368
(PKC-speciﬁc). In the presence of 8Br-cAMP, phosphorylation of
Cx43 increased (s20–30%) at both MAPK-sensitive sites (Ser255
and Ser279) compared with vehicle controls, reaching statisti-
cal signiﬁcance at the Ser279 site (Figure 8A). In comparison,
DADSsigniﬁcantlyincreased(s30%)phosphorylationatMAPK-
sensitive Ser255 and Ser279, the p34cdc2-sensitive Ser262, and the
PKC-sensitive Ser368 (Figure 8B).
DISCUSSION
Accumulating evidence indicates a regulatory role for connexins
andgapjunctioncommunicationinavarietyof vascularpatholo-
gies including hypertension (Figueroa et al., 2006; Brisset et al.,
2009) ischemia/reperfusion injury (Jara et al., 1995), atheroscle-
rosis (Blackburn et al., 1995; Polacek et al., 1997;Yeh et al., 1997),
and the growth response to vascular injury (Yeh et al., 1997; Kur-
jiaka et al., 1998; Brisset et al., 2009). Mechanistically, a variety of
controlling elements have been examined for Cx (Figueroa and
Duling, 2009), yet few reports have investigated a role for cyclic
nucleotides in the control of Cx43 expression and functionality
with respect to VSM growth. Hence, this study aimed to under-
stand the physiological relevance of Cx43 regulation by cyclic
nucleotide signaling in VSM growth. Using rat primary VSMCs,
thecyclicnucleotideanalog8Br-cAMPandthegarlic-deriveddial-
lylcompoundDADSreducedproliferationandDNAsynthesisand
increased Cx43 expression and functionality, establishing a direct
link between VSMC proliferation and Cx43. It was also observed
that distinct protein kinase signals have capacity to regulate Cx43
expression and functionality that are modulated by 8Br-cAMP
and DADS. In summary, this study provides direct evidence for
the mechanistic basis of gap junctional communication in the
regulation of VSMC proliferation.
In this study both metabolically stable, direct-activating cyclic
nucleotide analogs and indirect sGC stimulation were used to
induce cyclic nucleotide signaling. Using 8Br-cAMP and 8Br-
cGMP,after a 72-h exposure only 8Br-cAMP signiﬁcantly reduced
cell proliferation estimated by the MTT and hemocytometry
assays, conﬁrming an earlier report using a different cAMP ana-
log (Indolﬁ et al., 2000). In the current study it was interesting to
note that 8Br-cGMP failed to exert noticeable effects on VSMC
growth as earlier studies report anti-proliferative effects by stimu-
lation of cGMP-related pathways (Lincoln et al., 2006) but not
by cGMP per se. To complement ﬁndings from the prolifera-
tion assays,two additional approaches were employed to examine
VSMC growth. Bromodeoxyuridine uptake allows study of DNA
synthesis whereas ﬂow cytometry explores cell cycle progression.
Most reports studying the effects of cGMP on VSMC prolifera-
tion involve indirect cGMP stimulation that may have untoward
effects such as those mediated by cAMP considering that cGMP-
mediated inhibition of PDE3 increases cAMP levels (Maurice and
Haslam, 1990). Remarkably, neither 8Br-cAMP nor 8Br-cGMP
showedinﬂuenceontherateof DNAsynthesisestimatedbyBrdU
uptake after 6h. Nonetheless, using ﬂow cytometry 8Br-cAMP
showed insigniﬁcant decreases in S-phase and G2/M phase cells
with a slight increase in G0/G1 cells after 16h. The effects on
the nuclear mechanisms in the presence of 8Br-cAMP were not
evident at the acute time points analyzed; nonetheless,the inhibi-
tion of VSMC growth after 72h was signiﬁcant conﬁrming earlier
reports that elevated cAMP inhibits VSMC proliferation in vitro
(Wu et al., 2006).
Recent ﬁndings from our lab provide solid evidence that phar-
macologic sGC stimulation increases both cAMP and cGMP
(Adderley et al., 2012) and inhibits neointimal growth after bal-
looninjury(Joshietal.,2011).Inthecurrentstudyincomparison
to the effects of the cyclic nucleotide analogs, the sGC stimulator
BAY41-2272(BAY)didnotsigniﬁcantlyreduceDNAsynthesisbut
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FIGURE 4 |Total Cx43 expression inVSMCs. (A) In-cell Western blotting for
total Cx43 expression in rat primary VSMC homogenates. Incubation of rat
primaryVSMCs for 270min in the presence of 8Br-cAMP (100mM), 8Br-cGMP
(100mM), BAY (100nM), or DADS (50mM) signiﬁcantly stimulated total Cx43
expression normalized to a-tubulin. Data are from two independent
experiments each performed in triplicate. (B) After 24-h incubation the
stimulation of Cx43 was signiﬁcantly increased only after DADS treatment
with no observable changes for the 8Br-cAMP , 8Br-cGMP , or BAY treatment
groups compared with vehicle controls. For these experiments nD6 for each
treatment. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p <0.05 compared with normalized
vehicle controls. (C) A representative Western blot showing total Cx43 in
green and a-tubulin in red using IR-labeled antibodies.These data were
obtained from a single Western blot with a column (unrelated to the current
study) removed for clarity. (D) Photomicrograph of conﬂuentVSMCs following
immunocytochemical staining for total Cx43. Punctate appearance of Cx43
indicating the presence of gap junctions is predominantly at cell-to-cell
contacts (indicated by arrows).
reduced VSMC proliferation after 72h as reported earlier (Joshi
et al.,2011). This anti-proliferative effect of BAY was recently sug-
gested to occur through Cdk suppression and elevation of p21
and p27 (Mendelev et al., 2009); however, that study used BAY
at 10mM in commercial A7R5 VSMCs whereas the present study
used BAY at 100nM in primaryVSMCs.Additionally,this current
study and our recent report (Joshi et al.,2011) attribute decreases
in VSMC proliferation induced by BAY to changes in phospho-
rylation of vasodilator-activated serum phosphoprotein (VASP),
a marker of differential kinase activation (Butt et al., 1994), and
a critical cytoskeletal and focal adhesion element (Reinhard et al.,
2001).
In the current study a signiﬁcant reduction in VSMC growth
and DNA synthesis by DADS was complemented by a decrease
in the number of cells in the S-phase, estimated by ﬂow cytom-
etry. The inhibitory effects of DADS on cell growth in other
systemshavebeenmostlyattributedtoanincreaseintheapoptotic
cell populations correlated with depressed p34cdc2 kinase activity
(KnowlesandMilner,2000),andatthesametimeDADShasbeen
reported to be a potent stimulator of Cx43 expression and activity
(Huard et al., 2004). DADS has been reported to induce S-phase
block in tumorigenic CNE2 cells (Zhang et al.,2006),observed in
the present study inVSMCs as well.
Expression of Cx43 has been reported to be regulated by
cAMP in thymic epithelial cells (Nihei et al., 2010), but scien-
tiﬁc evidence is lacking for the effects of cAMP or cGMP on
Cx43 expression and functionality in primary VSM. The present
study exclusively used primary VSMCs to study the effects of the
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FIGURE 5 | Results from in-cellWestern analyses showing effects of
kinase inhibition on total Cx43 expression in rat primaryVSMCs
following incubation in the presence of (A) 8Br-cAMP (100mM), (B)
8Br-cGMP (100mM), (C) BAY (100nM), and (D) DADS (50mM) for 270min.
(A) Inhibition of PKA (by PKI), PKG (by DT2), or PKC (by CalC) each
independently subdued 8Br-cAMP-induced increase in Cx43 expression. (B,C)
Only PKG and PKC inhibition reversed the effects of 8Br-cGMP and BAY,
respectively. (D) Stimulation of Cx43 expression in the presence of DADS was
not dependent on PKA, PKG, or PKC. (E)Treatment with any individual kinase
inhibitor did not affect total basal Cx43 expression compared with vehicle
controls. Data are meanSE from nD4–7 for each treatment.
Student–Newman–Keuls method for multiple comparisons following one-way
ANOVA was used. *p <0.05 compared with normalized vehicle controls;
#p <0.05 comparing inhibitors to agonists alone normalized to vehicle controls.
brominated cyclic nucleotide analogs and BAY on Cx43 expres-
sion/functionality and to investigate the roles of PKA, PKG, and
PKC in mediating these events. Both 8Br-cAMP and 8Br-cGMP
stimulated total Cx43 protein expression providing direct evi-
dence for the regulation of Cx43 by cyclic nucleotides in VSMCs.
These cyclic nucleotide analogs are known to act via kinase path-
ways. The known inhibitors PKI, DT-2, and CalC were used for
respective inhibition of PKA,PKG,and PKC,and inhibition of all
the three individual kinases reversed 8Br-cAMP-stimulated Cx43
expression, providing direct evidence for the role of all the three
kinases in 8Br-cAMP-mediated stimulation of Cx43 expression.
At the same time an involvement of only the PKG and PKC path-
ways was evident in 8Br-cGMP stimulation of Cx43 expression
as only DT-2 and CalC reversed 8Br-cGMP-mediated stimulation
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Table 1 |Table showing the summary of the effect of 8Br-cAMP ,
8Br-cGMP , BAY, and DADS on Cx43 expression and the regulation of
this Cx43 stimulation by the respective kinases.
Kinase inhibitors
Treatment Total
Cx43
expression
w/PKI
(PKA
inhibition)
w/DT-2
(PKG
inhibition)
w/CalC
(PKC
inhibition)
8Br-cAMP " # # #
8Br-cGMP " – # #
BAY 41-2272 " – # #
DADS " – – –
of Cx43 expression. This is the ﬁrst report providing evidence for
involvement of cyclic nucleotide-mediated kinase pathways in the
regulation of Cx43 expression in primary VSM. In comparison
to these direct analogs, the sGC/cGMP stimulator BAY was also
observed to stimulate Cx43 expression that was reversed by the
inhibitionof PKGandPKC,thesamekinasesthatwereinvolvedin
thestimulationofCx43expressionby8Br-cGMP.Thediallylcom-
pound DADS is known to stimulate Cx43 in rat liver cells (Huard
et al., 2004), and in the current study was found to increase Cx43
expression and conductance in rat primary VSMCs. Interestingly,
these effects of DADS on Cx43 expression appear independent of
the kinase pathways studied here, namely PKA, PKG, or PKC.
Although 8Br-cAMP, 8Br-cGMP, BAY, and DADS each inde-
pendently increased Cx43 expression, it was only with 8Br-cAMP
and DADS that an increase in GJIC was observed conﬁrming
earlier reports (Huard et al., 2004; Nihei et al., 2010). Although
8Br-cGMP has been observed to increase GJIC in other tissues
such as the mesangium (Yao et al., 2005), similar effects on GJIC
were not observed in the rat primary VSMC in this study. It is
important to note that the increased GJIC reported earlier (Yao
et al., 2005) in the presence of 8Br-cGMP was in the presence
of a very high concentration of analog (500mM) and observed
after a 24-h incubation, whereas in the present study 8Br-cGMP
was used at 100mM for 15min under more physiologically real-
istic conditions. A high turnover rate (t1/2 1.5–3.5h; Laird et al.,
1991) has been observed for plasma membrane-localized Cx43.
Cx43 also possesses multiple phosphorylation sites (Lampe and
Lau, 2000). Thus, the purpose of using a shorter time point was
to avoid potential changes in Cx43 expression levels and to inves-
tigate if rapid phosphorylation of Cx43 coincided with changes in
GJIC. Furthermore, short-term incubation (30min) in the pres-
enceof 8Br-cAMP,8Br-cGMP,BAY,orDADShadnoeffectsonthe
Cx43expressionlevels(datanotshown).Anumberofreportshave
shown that increased cAMP increases Cx43 expression, function-
ality,andphosphorylation(LampeandLau,2004)andspeciﬁcally
the increase in Cx43 expression appears to be mediated by PKA
(Paulson et al., 2000) in hepatoma cells and it has only recently
been reported that the cAMP/PKA pathway regulates GJIC in
mouse embryonic stem cells (Yun et al., 2012). The stimulation
of GJIC by 8Br-cAMP observed in this study was reversed by the
PKCinhibitorCalC,anditwassurprisingtonotethatneitherPKA
norPKGhadanyroleinregulating8Br-cAMP-stimulatedGJIC.In
ratprimaryVSMCcrosstalkbetweenthedifferentkinaseshasbeen
reported (Adderley et al., 2012; Joshi et al., 2011). Moreover, the
differentkinasesmayplayvaryingrolesinregulatingCx43expres-
sion/functionality depending on their tissue/organ speciﬁcity and
perhaps precise localization within the cellular milieu (Adderley
et al., 2012).
In this effort the sGC modulator BAY did not exert noticeable
effectsonGJICinratprimaryVSMC.Thisistheﬁrstreportstudy-
ing the inﬂuence of BAY on Cx43 expression and functionality,
and although BAY has been reported to inhibit VSMC prolifera-
tion through cGMP-dependent pathways (Mendelev et al., 2009)
itdoesnotseemtobedependentuponafunctionalCx43.Itcould
be possible, however, that the BAY-stimulated increase in Cx43
expression may have delayed effects on VSMC proliferation that
were not evident at the time points observed in this study.
The diallyl garlic compound DADS has been reported to be
cancer chomopreventive in a number of studies (Schaffer et al.,
1996; Knowles and Milner, 2000; Arunkumar et al., 2006) and an
important characteristic of DADS is its ability to stimulate Cx43
expression and GJIC (Huard et al., 2004). There is increasing
evidence that GJIC alteration is involved in tumor cell develop-
ment (Trosko and Ruch, 1998), and most studies using DADS
have been performed on phenotypically modiﬁed or tumorigenic
cells. This is the ﬁrst report characterizing the effects of DADS
on VSMC Cx43 with respect to proliferation, and data reveal that
DADS stimulates acute GJIC. The shorter treatment time used
in this study (15min) is important as no changes in Cx43 pro-
tein expression were detected even after 30-min exposure, and
thus these ﬁndings signify direct, translation-independent acti-
vation of Cx43 leading to the opening of gap junction channels
and promoting GJIC. The inhibition of PKG by DT-2 reversed
DADS-promoted GJIC in the rat primary VSMCs which was not
reversed by either PKA or PKC inhibition. This observation indi-
cates involvement of the PKG pathway in DADS stimulation, and
in comparison with the role for PKC in the activation of GJIC
by 8Br-cAMP, clearly supports the notion of crosstalk between
the kinases that appears to be tissue- and function-speciﬁc. The
study also highlights the fact that the functionality of gap junc-
tions plays a more important role in regulating the prolifera-
tion of VSMC than does simple expression of the gap junction
proteins.
Considering the potential involvement of site-speciﬁc Cx43
phosphorylation in regulating GJIC that may control cell prolifer-
ation,phosphorylationofCx43wasstudiedattheMAPK-sensitive
sites Ser255 and Ser279, the cell cycle regulatory p34cdc2-sensitive
Ser262, and PKC-sensitive Ser368. Although both 8Br-cAMP and
DADS had similar effects on VSMC growth and Cx43 expression
and functionality, they have different site-speciﬁc Cx43 phos-
phorylation proﬁles. Using the ICW technique that is preferred
for evaluation of phosphorylated residues, 8Br-cAMP stimulated
Cx43 phosphorylation at only the MAPK-sensitive Ser255 and
Ser279 sites while DADS stimulated phosphorylation of Cx43 at
multiple sites including Ser255 and Ser279, Ser262 and Ser368.
Studies have demonstrated alteration in the proliferative state of a
cell with a loss of Cx43 (Solan et al.,2003;Shao et al.,2005;Norris
etal.,2008)oritsalteredphosphorylationstatus(Dangetal.,2006;
Solan and Lampe, 2007). Changes in Cx43 phosphorylation and
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FIGURE 6 | Gap junction intercellular communication (GJIC) as an
indicator of functionality estimated by ﬂuorescence recovery after
photobleaching (FRAP). (A) Incubation of rat primary VSMCs for 15min
in the presence of 8Br-cAMP (100mM) or DADS (50mM) signiﬁcantly
increased GJIC. Data are meanSE from an nD5–9 for each treatment.
Student–Newman–Keuls method for multiple comparisons following
one-way ANOVA was used. *p <0.05 compared with normalized vehicle
controls. (B–E) Representative photomicrographs (630) of conﬂuent
VSMCs undergoing FRAP with the targeted cell outlined. (B) Before
photobleaching; (C) immediately after photobleaching; (D) 2.5min after
photobleaching; and (E) 4.5min after photobleaching at the conclusion of
ﬂuorescence recovery.
gap junctional communication have also been observed as cells
proceed through the cell cycle (Koo et al., 1997; Xie et al., 1997;
Kanemitsu et al., 1998; Lampe et al., 1998; Bittman and LoTurco,
1999; Solan et al., 2003), indicating that GJIC and Cx43 phos-
phorylation are tightly regulated and linked during cell cycle. It is
important to note that the role of Cx43 phosphorylation may dif-
ferconsiderablyamongcelltypes,stagesofcellcycle,growthfactor
milieuandextracellularmatrixinteractions,andgivenitsshortt1/2
and rapid turnover, its phosphorylative capacity must be closely
regulated. Although a loss of GJIC has been reported in WB-F344
ratliverepithelialcells(Ruchetal.,2001)andintheIAR6.1ratliver
epithelial cell (Rivedal and Opsahl,2001) line after TPA treatment
alongwithCx43phosphorylationattheMAPKactivesites,Ser255
and Ser279,a similar effect was not seen in the rat primaryVSMC
after 8Br-cAMP and DADS. In fact, increased phosphorylation
of Cx43 at Ser255 and Ser279, MAPK-sensitive sites, correlated
with reduced VSMC growth and improved GJIC. Ser262 is a
p34cdc2-sensitive phosphorylation site that has been reported to
be involved in cell division (Laird, 2005). Following phosphory-
lation of Cx43 at Ser262 by p34cdc2 protein kinase, a loss of gap
junction coupling was observed in Rat1 and human endothelial
cells (Lampe et al., 1998). Conversely, in this study in the pres-
ence of DADS an increase in Cx43 phosphorylation at Ser262 and
GJIC in rat primary VSMC was observed with a decrease in pro-
liferation. These differences can be attributed to unique cellular
systems and treatment times, and most importantly, the role of
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FIGURE 7 | Effect of kinase inhibition on (A) 8Br-cAMP- and (B)
DADS-stimulated GJIC estimated by FRAP . Rat primaryVSMCs were
incubated for 15min in the presence of the following PKA, PKG, and
PKC inhibitors: PKI (10mM), DT-2 (10mM), and Calphostin-C (100nM),
respectively, followed by 8Br-cAMP (100mM) or DADS (50mM) alone
for 15min. (A) Stimulation of GJIC by 8Br-cAMP was effectively
inhibited by PKC inhibition alone but not by inhibition of PKA or PKG.
(B) DADS-mediated GJIC stimulation was partially (non-signiﬁcantly)
reversed by PKA or PKG inhibition. Data are meanSE from an nD4
for the inhibitors treatment and an nD6–9 for control, 8Br-cAMP and
DADS. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p <0.05 compared with
normalized vehicle controls,
#p <0.05 compared with cAMP-treated
cells.
FIGURE 8 | In-cellWestern analyses of site-speciﬁc Cx43
phosphorylation in rat primaryVSMCs in the presence of (A)
8Br-cAMP and (B) DADS. (A) In the presence of 8Br-cAMP ,
phosphorylation of the MAPK-sensitive Ser279 was signiﬁcantly increased
compared to vehicle controls. (B)The presence of DADS signiﬁcantly
increased phosphorylation at the MAPK sensitive Ser255 and Ser279
sites, p34
cdc2 kinase-sensitive Ser262, and the PKC-sensitive Ser368. Data
are meanSE from three independent experiments with an nD4 for
Ser279 phosphorylation, and nD3–4 for Ser255, 262, and 368
phosphorylation. Student–Newman–Keuls method for multiple
comparisons following one-way ANOVA was used. *p <0.05 compared
with respective vehicle controls.
Cx43 phosphorylation may be entirely cell-or tissue-speciﬁc that
may also depend on the stages of cell growth.
Phosphorylation of Cx43 on Ser368 is mediated by PKC, and
earlier reports using rat epithelial T51B cells strongly suggest that
PKC directly phosphorylates Cx43 on Ser368 in vivo that con-
tributes to a decrease in intercellular communication (Lampe
et al., 2000) and that promotes carcinogenesis (Berthoud et al.,
1992). These ﬁndings have served as the basis for the hypothesis
that reduced cell–cell communication is a critical step in multi-
stage carcinogenesis. The focus of the present study however was
growth of normal VSMC and not modiﬁed or cancerous cells.
Contrary to the earlier report (Lampe et al.,2000),in neonatal rat
cardiomyocytes activation of PKC has been reported to cause an
increase in junctional conductance (Kwak et al., 1995). The rea-
son for these differences is not yet explained. In the present study
GJIC stimulated by 8Br-cAMP was mediated by PKC, while that
by DADS appeared to be mediated by PKG. Although 8Br-cAMP
did not have any effects on the PKC-sensitive phosphorylation
site Ser368 on Cx43, DADS signiﬁcantly increased phosphoryla-
tion at this site with a decrease in VSMC growth, and possibly as
shown earlier in the cardiomyocytes (Kwak et al., 1995; Kwak and
Jongsma,1996)theCx43inthecardiovascularsystemmaybehave
differently than in other cell/tissue types.
Itshouldbenotedthattheprimarycellsusedinthisstudywere
derivedfromthoracicaorta.VSMCsofbothresistanceandconduit
arteriesexpresspredominantlyCx43andCx45(Littleetal.,1995),
and the expression of connexin proteins has been reported to vary
particularly in arterioles and small arteries (Schmidt et al., 2008).
In addition to this potential vascular heterogeneity among con-
nexinisotypes,itisimportanttonotethatconnexinsintheintimal
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endotheliumandadjacentmedialwallarecriticalintheregulation
of gross vessel function. Vasoconstrictor and vasodilatory signals
travel rapidly along the vessel network due to the conduction of
signals between endothelial and smooth muscle cells (Beny and
Connat,1992),andtheseoccurthroughgapjunctions.Thespread
of conducted dilations which travel large distances along the ves-
sel are facilitated more by the endothelium, whereas conducted
constrictions rely primarily on the smooth muscle. Even though
the anatomical characteristics of endothelial cells may provide a
more efﬁcient pathway to coordinate vascular behavior (Haas and
Duling,1997),in this study the focus was on connexin physiology
of medial wall-derivedVSMCs.
It should also be noted that for many of the endpoints ana-
lyzed in this study, the overall changes generally ranged between
20 and 40% (with exceptions with the GJIC and inhibitor studies
which demonstrated larger effects), and this may raise concerns
over their physiological relevance. In comparison, the original
characterization of DADS as an inducer of both Cx43 expression
and functionality (Huard et al., 2004) reported increases in GJIC
between 10 and 30% after 8-h treatment with DADS and 50%
after 24h, agreeing closely with observations in the current study.
Thus, in comparison with this original report using DADS as a
stimulatory agonist,in the current study the observed changes are
considered highly signiﬁcant and physiologically relevant.
In summary, this study demonstrates a critical role of Cx43
in growth of primary VSM and supports a direct correlation
between proliferation and Cx43 expression and gap junction
communication. It is important to note that increased expres-
sion alone may not lead to increased gap junction communi-
cation, and that opening of the channels with functional con-
ductance is the rate-limiting step in cell–cell communication.
In this study Cx43-mediated GJIC was found to operate inde-
pendently of site-speciﬁc Cx43 phosphorylation, demonstrating
that the role of Cx43 phosphorylation may be mostly depen-
dent on the type of cell/tissue. These ﬁndings may open new
avenues for further understanding the factors that regulateVSMC
growth.
ACKNOWLEDGMENTS
This study was supported by the ECU Undergraduate Research
and Creative Activity Award (DNM), National Institutes of
Health National Heart, Lung, and Blood Institute Grant R01-
HL081720 and NIH American Recovery and Reinvestment Act
(2009) Grant R01-HL081720-03S2. We thank Jonathan Clay
Fox for providing technical assistance cell culture and Shaquria
P. Adderley, Ph.D., Brody School of Medicine, East Carolina
University, Greenville, NC for valuable discussions related to
this work.
REFERENCES
Adderley, S. P., Joshi, C. N., Martin,
D. N., and Tulis, D. A. (2012).
Phosphodiesterases regulate BAY
41-2272-induced VASP phosphory-
lation in vascular smooth mus-
cle cells. Front. Pharmacol. 3:10.
doi:10.3389/fphar.2012.00010
Arunkumar, A., Vijayababu, M. R.,
Venkataraman, P., Senthilkumar, K.,
and Arunakaran, J. (2006). Chemo-
prevention of rat prostate car-
cinogenesis by diallyl disulﬁde, an
organosulfur compound of garlic.
Biol. Pharm. Bull. 29, 375–379.
Beny, J. L., and Connat, J. L. (1992).
An electron-microscopic study of
smooth muscle cell dye coupling in
thepigcoronaryarteries.Roleof gap
junctions. Circ. Res. 70, 49–55.
Berthoud, V. M., Ledbetter, M. L. S.,
Hertzberg, E. L., and Saez, J. C.
(1992). Connexin43 in MDCK cells:
Regulation by a tumor-promoting
phorbol ester and calcium. Eur. J.
Cell Biol. 57, 40–50.
Bittman, K. S., and LoTurco, J. J.
(1999). Differential regulation of
connexin 26 and 43 in murine neo-
cortical precursors. Cereb. Cortex 9,
188–195.
Blackburn, J. P., Peters, N. S.,Yeh, H. I.,
Rothery,S.,Green,C. R.,and Severs,
N. J. (1995). Upregulation of con-
nexin43 gap junctions during early
stages of human coronary athero-
sclerosis. Arterioscler. Thromb. Vasc.
Biol. 15, 1219–1228.
Brisset, A. C., Isakson, B. E., and Kwak,
B. R. (2009). Connexins in vascular
physiology and pathology. Antioxid.
Redox Signal. 11, 267–282.
Butt, E., Abel, K., Krieger, M., Palm,
D., Hoppe, V., Hoppe, J., and Wal-
ter, U. (1994). cAMP and cGMP-
dependent protein kinase phospho-
rylation sites of the focal adhe-
sion vasodilator-stimulated phos-
phoprotein (VASP) in vitro and in
intacthumanplatelets.J.Biol.Chem.
269, 14509–14517.
Chadjichristos, C. E., Morel, S., Derou-
ette, J. P., Sutter, E., Roth, I., Brisset,
A. C., Bochaton-Piallat, M. L., and
Kwak, B. R. (2008). Targeting con-
nexin 43 prevents platelet-derived
growth factor-BB-induced pheno-
typic change in porcine coronary
arterysmoothmusclecells.Circ.Res.
102, 653–660.
Chen, H., Kovar, J., Sissons, S.,
Cox, K., Matter, W., Chadwell, F.,
Luan, P., Vlahos, C. J., Schutz-
Geschwender, A., and Olive, D.
M. (2005). A cell-based immuno-
cytochemical assay for monitor-
ing kinase signaling pathways and
drug efﬁcacy. Anal. Biochem. 338,
136–142.
Cooper, C. D., Solan, J. L., Dole-
jsi, K. K., and Lampe, P. D.
(2000). Analysis of connexin phos-
phorylation sites. Methods 20,
196–204.
Coutinho,P.,Qiu,C.,Frank,S.,Tamber,
K., and Becker, D. (2003). Dynamic
changes in connexin expression cor-
relate with key events in the wound
healing process. Cell Biol. Int. 27,
525–541.
Dang, X., Jeyaraman, M., and Kar-
dami, E. (2006). Regulation of
connexin-43-mediatedgrowthinhi-
bitionbyaphosphorylatableamino-
acid is independent of gap junction-
forming ability. Mol. Cell. Biochem.
289, 201–207.
Dey, N. B., Foley, K. F., Lincoln, T. M.,
and Dostmann, W. R. (2005). Inhi-
bition of cGMP dependent protein
kinase reverses phenotypic modu-
lation of vascular smooth muscle
cells. J. Cardiovasc. Pharmacol. 45,
404–413.
Dostmann, W. R., Tegge, W., Frank,
R., Nickl, C. K., Taylor, M. S., and
Brayden, J. E. (2002). Exploring the
mechanisms of vascular smooth
muscle tone with highly speciﬁc,
membrane-permeable inhibitors
of cyclic GMP-dependent protein
kinase Ia. Pharmacol. Ther. 93,
203–215.
Durante, W, Schini, V. B., Catovsky,
S., Kroll, M. H., Vanhoutte, P. M.,
and Schafer, A. I. (1993). Plasmin
potentiates induction of nitric oxide
synthase in vascular smooth mus-
cle cells. Am. J. Physiol. 264, H617–
H624.
Evans, W. H., and Martin, P. E.
(2002).Gapjunctions:structureand
function. Mol. Membr. Biol. 19,
121–136.
Figueroa,X.F.,andDuling,B.R.(2009).
Gap junctions in the control of vas-
cular function. Antioxid. Redox Sig-
nal. 11, 251–266.
Figueroa, X. F., Isakson, B. E., and Dul-
ing, B. R. (2006). Vascular gap junc-
tions in hypertension. Hypertension
48, 804–811.
Giordano,A.,Romano,S.,Mallardo,M.,
D’Angelillo, A., Calí, G., Corcione,
N., Ferraro P., and Romano, M. F.
(2008). FK506 can activate trans-
forming growth factor-b signalling
in vascular smooth muscle cells and
promote proliferation. Cardiovasc.
Res. 79, 519–526.
Goodwin, J. S., and Kenworthy, A. K.
(2005). Photobleaching approaches
to investigate diffusional mobility
and trafﬁcking of Ras in living cells.
Methods 37, 154–164.
Haas, T. L., and Duling, B. R. (1997).
Morphology favors an endothelial
cell pathway for longitudinal con-
ductionwithinarterioles.Microvasc.
Res. 53, 113–120.
Haeﬂiger, J. A., Nicod, P., and Meda. P.
(2004). Contribution of connexins
to the function of the vascular wall.
Cardiovasc. Res. 62, 345–356.
Huard, C., Druesne, N., Guyonnet, D.,
Thomas, M., Pagniez, A., Le Bon,
A. M., Martel, P., and Chaumontet,
C. (2004). Diallyl disulﬁde (DADS)
enhances gap-junctional intercellu-
lar communication by both direct
and indirect mechanisms in rat liver
cells. Carcinogenesis 25, 91–98.
www.frontiersin.org June 2012 | Volume 3 | Article 220 | 11Joshi et al. Cx43 and VSMC growth
Indolﬁ, C., Di Lorenzo, E., Rapacci-
uolo, A., Stingone, A. M., Stabile,
E., Leccia, A., Torella, D., Caputo,
R., Ciardiello, F., Tortora, G., and
Chiariello, M. (2000). 8-chloro-
cAMP inhibits smooth muscle cell
proliferation in vitro and neointima
formationinducedbyballooninjury
in vivo. J. Am. Coll. Cardiol. 36,
288–293.
Isakson, B. E., Damon, D. N., Day,
K. H., Liao, Y., and Duling, B.
R. (2006). Connexin40 and con-
nexin43 in mouse aortic endothe-
lium: evidence for coordinated reg-
ulation. Am. J. Physiol. Heart Circ.
Physiol. 290, H1199–H1205.
Jara, P. I., Boric, M. P., and Saez,
J. C. (1995). Leukocytes express
connexin 43 after activation with
lipopolysaccharide and appear to
form gap junctions with endothe-
lial cells after ischemia-reperfusion.
Proc. Natl. Acad. Sci. U.S.A. 92,
7011–7015.
Johnstone, S., Isakson, B., and Locke,
D. (2009). Biological and biophys-
ical properties of vascular connexin
channels.Int.Rev.CellMol.Biol.278,
69–118.
Joshi, C. N., Martin, D. N., Fox, J.
C., Mendelev, N. N., Brown, T. A.,
and Tulis, D. A. (2011). The soluble
guanylatecyclasestimulatorBAY41-
2272 inhibits vascular smooth mus-
cle growth through the PKA and
PKG pathways. J. Pharmacol. Exp.
Ther. 339, 394–402.
Kanemitsu, M. Y., Jiang, W., and Eck-
hart, W. (1998). Cdc2-mediated
phosphorylation of the gap junction
protein,connexin43,duringmitosis.
Cell Growth Differ. 9, 13–21.
Knowles,L.M.,andMilner,J.A.(2000).
Allyl sulﬁdes modify cell growth.
Drug Metabol. Drug. Interact. 17,
81–107.
Koo, S. K., Kim, D. Y., Park, S. D., Kang,
K. W., and Joe, C. O. (1997). PKC
phosphorylation disrupts gap junc-
tionalcommunicationatG0/Sphase
in clone 9 cells. Mol. Cell. Biochem.
167, 41–49.
Kumar, N. M., and Gilula, N. B. (1996).
The gap junction communication
channel. Cell 84, 381–388.
Kurjiaka, D. T., Steele, T. D., Olsen, M.
V.,and Burt,J. M. (1998). Gap junc-
tion permeability is diminished in
proliferating vascular smooth mus-
cle cells. Am. J. Physiol. 275, C1674–
C1682.
Kwak, B. R., and Jongsma, H. J. (1996).
Regulation of cardiac gap junction
channel permeability and conduc-
tance by several phosphorylating
conditions. Mol. Cell. Biochem. 157,
93–99.
Kwak, B. R., Mulhaupt, F., Veillard, N.,
Gros, D. B., and Mach, F. (2002).
Altered pattern of vascular con-
nexin expression in atherosclerotic
plaques. Arterioscler. Thromb. Vasc.
Biol. 22, 225–230.
Kwak, B. R., Van Veen, T. A. B., Anal-
bers, L. J. S., and Jongsma, H. J.
(1995). TPA increases conductance
butdecreasespermeabilityinneona-
tal rat cardiomyocyte gap junc-
tion channels. Exp. Cell Res. 220,
456–463.
Laird, D. W. (2005). Connexin phos-
phorylation as a regulatory event
linked to gap junction internaliza-
tion and degradation. Biochim. Bio-
phys. Acta 1711, 172–182.
Laird, D. W., Puranam, K. L., and
Revel, J. P. (1991). Turnover and
phosphorylation dynamics of con-
nexin43 gap junction protein in cul-
tured cardiac myocytes. Biochem. J.
273, 67–72.
Lampe, P. D., Kurata, W. E., Warn-
Cramer, B., and Lau, A. F. (1998).
Formation of a distinct connexin43
phosphoisoform in mitotic cells is
dependent upon p34cdc2 kinase. J.
Cell. Sci. 111, 833–841.
Lampe, P. D., and Lau, A. F. (2000).
Regulation of gap junctions by
phosphorylationof connexins.Arch.
Biochem. Biophys. 384, 205–215.
Lampe, P. D., and Lau, A. F. (2004).
The effects of connexin phosphory-
lation on gap junctional communi-
cation. Int. J. Biochem. Cell Biol. 36,
1171–1186.
Lampe, P. D., TenBroek, E. M., Burt, J.
M., Kurata, W. E., Johnson, R. G.,
and Lau, A. F. (2000). Phosphoryla-
tion of connexin43 on serine368 by
protein kinase c regulates gap junc-
tional communication. J. Cell Biol.
149, 1503–1512.
Liao, Y., Regan, C. P., Manabe, I.,
Owens, G. K., Day, K. H., Damon,
D. N., and Duling, B. R. (2007).
Smooth muscle-targeted knockout
of connexin43 enhances neointimal
formation in response to vascular
injury. Arterioscler. Thromb. Vasc.
Biol. 27, 1037–1042.
Lincoln, T. M., Wu, X., Sellak, H., Dey,
N., and Choi, C. S. (2006). Reg-
ulation of vascular smooth mus-
cle cell phenotype by cyclic GMP
and cyclic GMP-dependent protein
kinase. Front. Biosci. 11, 356–367.
Little, T. L., Beyer, E. C., and Duling,
B. R. (1995). Connexin 43 and con-
nexin 40 gap junctional proteins are
present in arteriolar smooth mus-
cle and endothelium in vivo. Am. J.
Physiol. 268, H729–H739.
Liu, X. M., Peyton, K. J., Mendelev,
N. N., Wang, H., Tulis, D. A., and
Durante, W. (2009). YC-1 stim-
ulates the expression of gaseous
monoxide-generating enzymes in
vascular smooth muscle cells. Mol.
Pharmacol. 75, 208–217.
Maurice,D.H.,andHaslam,R.J.(1990).
Molecular basis of the synergistic
inhibition of platelet function by
nitrovasodilators and activators of
adenylatecyclase:inhibition of cyclic
AMP breakdown by cyclic GMP.
Mol. Pharmacol. 37, 671–681.
Mendelev, N. N., Williams, V. S., and
Tulis, D. A. (2009). Antigrowth
properties of BAY 41-2272 in vascu-
lar smooth muscle cells. J. Cardio-
vasc. Pharmacol. 53, 121–131.
Muller-Borer,B.J.,Cascio,W.E.,Ander-
son, P. A. W., Snowwaert, J. N., Frye,
J. R., Desai, N., Bagnell, C. R., Cole-
man, W. B., Grisham, J. W., and
Malouf, N. N. (2004). Adult derived
liver stem cells acquire a cardiac
myocyte structural and functional
phenotype in culture. Am. J. Pathol.
165, 135–145.
Nihei, O. K., Fonseca, P. C., Rubim,
N. M., Bonavita, A. G., Lyra, J. S.,
Neves-dos-Santos, S., de Carvalho,
A. C., Spray, D. C., Savino, W.,
and Alves, L. A. (2010). Modula-
tory effects of cAMP and PKC acti-
vation on gap junctional intercellu-
lar communication among thymic
epithelial cells. BMC Cell Biol. 11, 3.
doi:10.1186/1471-2121-11-3
Norris, R. P., Freudzon, M., Mehlmann,
L. M., Cowan, A. E., Simon, A. M.,
Paul, D. L., Lampe, P. D., and Jaffe,
L. A. (2008). Luteinizing hormone
causesMAPkinasedependentphos-
phorylationandclosureof connexin
43 gap junctions in mouse ovarian
follicles: one of two paths to mei-
otic resumption. Development 135,
3229–3238.
Paulson, A. F., Lampe, P. D., Meyer,
R. A., Atkinson, M. A., Walseth,
T. F., and Johnson, R. G. (2000).
Cyclic AMP and LDL trigger a rapid
enhancementingapjunctionassem-
bly through a stimulation of con-
nexin trafﬁcking. J. Cell. Sci. 113,
3037–3049.
Polacek, D., Bech, F., McKinsey, J.
F., and Davies, P. F. (1997). Con-
nexin43 gene expression in the rab-
bit arterial wall: effects of hyperc-
holesterolemia, balloon injury and
their combination. J. Vasc. Res. 34,
19–30.
Reinhard, M., Jarchau, T., and Wal-
ter, U. (2001). Actin-based motil-
ity: stop and go with Ena/VASP
proteins. Trends Biochem. Sci. 26,
243–249.
Rivedal,E.,and Opsahl,H. (2001). Role
ofPKCandMAPkinaseinEGF-and
TPA-induced connexin43 phospho-
rylation and inhibition of gap junc-
tion intercellular communication in
rat liver epithelial cells. Carcinogen-
esis 22, 1543–1550.
Ruch,R. J.,Trosko,J. E.,and Madhukar,
B. V. (2001). Inhibition of con-
nexin43 gap junctional intercellu-
lar communication by TPA requires
ERK activation. J. Cell. Biochem. 83,
163–169.
Saitongdee, P., Becker, D. L., Milner,
P., Knight, G. E., and Burnstock, G.
(2004). Levels of gap junction pro-
teinsincoronaryarteriolesandaorta
of hamsters exposed to the cold and
during hibernation and arousal. J.
Histochem. Cytochem. 52, 603–615.
Schaffer, E. M., Liu, J. Z., Green,
J., Dangler, C. A., and Milner, J.
A. (1996). Garlic and associated
allyl sulfur compounds inhibit N-
methyl-N-nitrosourea induced rat
mammary carcinogenesis. Cancer
Lett. 102, 199–204.
Schlegel, N., and Waschke, J. (2009).
VASP is involved in cAMP-mediated
Rac 1 activation in microvascular
endothelial cells. Am. J. Physiol. Cell
Physiol. 296, C453–C462.
Schmidt, V. J., Wölﬂe, S. E., Boettcher,
M., and de Wit C. (2008). Gap
junctions synchronize vascular tone
within the microcirculation. Phar-
macol. Rep. 60, 68–74.
Shao, Q., Wang, H., McLachlan, E.,
Veitch,G.I.,andLaird,D.W.(2005).
Down-regulation of Cx43 by retro-
viral delivery of small interfering
RNA promotes an aggressive breast
cancer cell phenotype. Cancer Res.
65, 2705–2711.
Shen,J.,Wang,L. H.,Zheng,L. R.,Zhu,
J.H.,andHu,S.J.(2010).Lovastatin
inhibits gap junctional communica-
tion in cultured aortic smooth mus-
cle cells. J. Cardiovasc. Pharmacol.
Ther. 15, 296–302.
Solan, J. L., Fry, M. D. TenBroek, E.
M., and Lampe, P. D. (2003). Con-
nexin43 phosphorylation at S368 is
acute during S and G2/M and in
response to protein kinase C activa-
tion. J. Cell Sci. 116, 2203–2211.
Solan,J.L.,andLampe,P.D.(2007).Key
connexin43phosphorylationevents
regulatethegapjunctionlifecycle.J.
Membr. Biol. 217, 35–41.
Touyz,R.M.,andSchiffrin,E.L.(1997).
Growthfactorsmediateintracellular
signaling in vascular smooth mus-
cle cells through protein kinase C-
linked pathways. Hypertension 30,
1440–1447.
Trosko, J. E., and Ruch, R. J. (1998).
Cell–cellcommunicationincarcino-
genesis. Front. Biosci. 15, D208–
D236.
Frontiers in Physiology | Vascular Physiology June 2012 | Volume 3 | Article 220 | 12Joshi et al. Cx43 and VSMC growth
Wade, M. H., Trosko, J. E., and
Schindler, M. (1986). A ﬂuores-
cence photobleaching assay of gap
junction-mediated communication
between human cells. Science 232,
525–528.
Wu, Y., Bond, M., Sala-Newby, G.,
and Newby, A. (2006). Altered S-
phase kinase-associated protein-2
levels are a major mediator of
cyclicnucleotide-inducedinhibition
of vascular smooth muscle cell pro-
liferation. Circ. Res. 98, 1141–1150.
Xie,H.,Laird,D. W.,Chang,T. -H.,and
Hu, V. W. (1997). A mitosis-speciﬁc
phosphorylation of the gap junction
protein connexin43 in human vas-
cular cells: Biochemical characteri-
zation and localization. J. Cell Biol.
137, 203–210.
Yamasaki, H., Krutovskikh, V., Mesnil,
M.,andOmori.,andY.(1996).Con-
nexin genes and cell growth control.
Arch. Toxicol. 18, 105–114.
Yamasaki, H., and Naus, C. C. G.
(1996). Role of connexin genes in
growth control. Carcinogenesis 17,
1199–1213.
Yao,J.,Hiramatsu,N.,Zhu,Y.,Morioka,
T., Takeda, M., Oite, T., and Kita-
mura, M. (2005). Nitric oxide-
mediated regulation of connexin43
expression and gap junctional inter-
cellular communication in mesan-
gial cells. J. Am. Soc. Nephrol. 16,
58–67.
Yeh, H. I., Lupu, F., Dupont, E., and
Severs,N. J. (1997). Upregulation of
connexin43 gap junctions between
smooth muscle cells after balloon
catheter injury in the rat carotid
artery. Arterioscler. Thromb. Vasc.
Biol. 17, 3174–3184.
Yun, S. P., Ryu, J. M., Park, J. H.,
Kim, M. O., Lee, J. H., and Han,
H. J. (2012). Prostaglandin E2
maintains mouse ESC undifferen-
tiated state through regulation of
connexin31,-43and-45expression:
Involvement of glycogen synthase
kinase 3b/b-catenin. Biol. Cell.
doi:10.1111/boc.201100032. [Epub
ahead of print].
Zhang,W.,DeMattia,J.A.,Song,H.,and
Couldwell, W. T. (2003). Commu-
nication between malignant glioma
cells and vascular endothelial cells
through gap junctions. J. Neurosurg.
98, 846–853.
Zhang, Y. W., Wen, J., Xiao, J. B., Tal-
bot, S. G., Li, G. C., and Xu, M.
(2006). Induction of apoptosis and
transientincreaseofphosphorylated
MAPKs by diallyl disulﬁde treat-
mentinhumannasopharyngealcar-
cinoma CNE2 cells. Arch. Pharm.
Res. 29, 1125–1131.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received:04April2012;accepted:01June
2012; published online: 21 June 2012.
Citation: Joshi CN, Martin DN, Shaver
P, Madamanchi C, Muller-Borer BJ
and Tulis DA (2012) Control of vascu-
lar smooth muscle cell growth by con-
nexin 43. Front. Physio. 3:220. doi:
10.3389/fphys.2012.00220
This article was submitted to Frontiers
in Vascular Physiology, a specialty of
Frontiers in Physiology.
Copyright © 2012 Joshi, Martin, Shaver,
Madamanchi, Muller-Borer and Tulis.
This is an open-access article distributed
underthetermsoftheCreativeCommons
Attribution Non Commercial License,
which permits non-commercial use, dis-
tribution, and reproduction in other
forums,providedtheoriginalauthorsand
source are credited.
www.frontiersin.org June 2012 | Volume 3 | Article 220 | 13